Sarepta Therapeutics
SRPT
#1563
Rank
โ‚น954.59 B
Marketcap
โ‚น9,994
Share price
-1.75%
Change (1 day)
-0.26%
Change (1 year)
Sarepta Therapeutics is an American medical research company dedicated to the discovery and development of precisely effective gene therapeutics for the treatment of rare neuromuscular diseases.

EPS for Sarepta Therapeutics (SRPT)

EPS in 2023 (TTM): -โ‚น644.14

According to Sarepta Therapeutics 's latest financial reports the company's current EPS (TTM) is -โ‚น677.79. In 2022 the company made an earnings per share (EPS) of -โ‚น695.10 a decrease over its 2021 EPS that were of -โ‚น445.80.

EPS history for Sarepta Therapeutics from 1997 to 2023

Annual EPS

Year EPS Change
2023 (TTM)-โ‚น644.14-7.33%
2022-โ‚น695.1055.92%
2021-โ‚น445.80-27.16%
2020-โ‚น612.00-26.96%
2019-โ‚น837.9378.6%
2018-โ‚น469.17603.9%
2017-โ‚น66.65-85.9%
2016-โ‚น472.635.2%
2015-โ‚น449.2653.1%
2014-โ‚น293.45-0%
2013-โ‚น293.45-33.79%
2012-โ‚น443.207214.29%
2011-โ‚น6.06-96.11%
2010-โ‚น155.8115.38%
2009-โ‚น135.04-23.53%
2008-โ‚น176.59-37.04%
2007-โ‚น280.46-0%
2006-โ‚น280.4645.95%
2005-โ‚น192.17-46.38%
2004-โ‚น358.3740.82%
2003-โ‚น254.49-57.02%
2002-โ‚น592.09-2.56%
2001-โ‚น607.67138.78%
2000-โ‚น254.49-20.97%
1999-โ‚น322.01-72.2%
1998-โ‚น1,158519.44%
1997-โ‚น186.98

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
โ‚น380.01-156.07%๐Ÿ‡บ๐Ÿ‡ธ USA
-โ‚น622.39-8.17%๐Ÿ‡บ๐Ÿ‡ธ USA
-โ‚น268.35-60.41%๐Ÿ‡บ๐Ÿ‡ธ USA
-โ‚น108.20-84.04%๐Ÿ‡บ๐Ÿ‡ธ USA
-โ‚น355.77-47.51%๐Ÿ‡บ๐Ÿ‡ธ USA
-โ‚น748.77 10.47%๐Ÿ‡บ๐Ÿ‡ธ USA
-โ‚น456.19-32.69%๐Ÿ‡บ๐Ÿ‡ธ USA